Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00224575
Status:
TERMINATED
Last Update Posted:
2016-03-08
First Post:
2005-09-13
Brief Title:
Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Therapeutical Impact of a Reassessment Strategy in the Diagnosis of Coronary Heart Disease in Elderly
Status:
TERMINATED
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
End of recruitment period
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IRIDIA
Brief Summary:
Despite the effectiveness of beta-blockers and antiplatelet agents for secondary prevention of coronary heart disease this treatments are underused in the elderly because of diagnosis uncertainty and underuse of efficient treatment
in a first time diagnosis reassessment with invasive technique if necessary in a second time treatment reassessment
in a first time diagnosis reassessment with invasive technique if necessary in a second time treatment reassessment
Detailed Description:
not desired
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None